Published in Infect Immun on June 30, 2008
Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med (2009) 5.55
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology (2010) 3.51
Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol (2009) 3.01
Critical role of IL-17RA in immunopathology of influenza infection. J Immunol (2009) 2.51
An overview of IL-17 function and signaling. Cytokine (2008) 2.38
The dual nature of T(H)17 cells: shifting the focus to function. Nat Immunol (2010) 1.78
The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev (2010) 1.64
Interleukin-17 and its expanding biological functions. Cell Mol Immunol (2010) 1.55
Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS One (2012) 1.19
Immunity to infection in IL-17-deficient mice and humans. Eur J Immunol (2012) 1.18
IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J Immunol (2011) 1.08
Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Res Ther (2013) 1.05
Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J Immunol (2009) 1.04
Morphine disrupts interleukin-23 (IL-23)/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection. Infect Immun (2009) 0.99
A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. Eur J Immunol (2009) 0.98
Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J Exp Med (2014) 0.96
IL-17 and anti-bacterial immunity: protection versus tissue damage. Eur J Immunol (2009) 0.96
Langerhans cells down-regulate inflammation-driven alveolar bone loss. Proc Natl Acad Sci U S A (2012) 0.93
Tailored immune responses: novel effector helper T cell subsets in protective immunity. PLoS Pathog (2014) 0.92
IL-17A induces signal transducers and activators of transcription-6-independent airway mucous cell metaplasia. Am J Respir Cell Mol Biol (2013) 0.91
RANKL expression in periodontal disease: where does RANKL come from? Biomed Res Int (2014) 0.90
Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders. Curr Allergy Asthma Rep (2013) 0.87
Rheumatoid arthritis and the role of oral bacteria. J Oral Microbiol (2010) 0.87
Sex-specific environmental influences on the development of autoimmune diseases. Clin Immunol (2013) 0.86
Antigen-specific CD25- Foxp3- IFN-gamma(high) CD4+ T cells restrain the development of experimental allergic encephalomyelitis by suppressing Th17. Am J Pathol (2010) 0.80
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III. Evid Based Complement Alternat Med (2011) 0.80
Gene expression and distribution of key bone turnover markers in the callus of estrogen-deficient, vitamin D-depleted rats. Calcif Tissue Int (2010) 0.79
Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management? Open Access Rheumatol (2010) 0.79
Interleukin 17 is a chief orchestrator of immunity. Nat Immunol (2017) 0.77
Interleukin-17 and interleukin-18 levels in different stages of inflammatory periodontal disease. J Indian Soc Periodontol (2015) 0.77
Pro-inflammatory, Th1, Th2, Th17 cytokines and dendritic cells: a cross-sectional study in chronic periodontitis. PLoS One (2014) 0.77
IL23R(Arg381Gln) functional polymorphism is associated with active pulmonary tuberculosis severity. Clin Vaccine Immunol (2012) 0.77
Interleukin-17A Gene Variability in Patients with Type 1 Diabetes Mellitus and Chronic Periodontitis: Its Correlation with IL-17 Levels and the Occurrence of Periodontopathic Bacteria. Mediators Inflamm (2016) 0.77
Control of Francisella tularensis Intracellular Growth by Pulmonary Epithelial Cells. PLoS One (2015) 0.75
The effect of periodontal scaling and root polishing on serum IL-17E concentrations and the IL-17A:IL-17E ratio. Clin Oral Investig (2016) 0.75
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity (2006) 29.29
Transforming growth factor-beta induces development of the T(H)17 lineage. Nature (2006) 25.91
IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature (2007) 16.59
IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol (2007) 16.21
IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol (2007) 14.99
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem (2002) 14.34
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature (2007) 14.28
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med (2001) 12.38
TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol (2007) 11.14
A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med (2007) 8.97
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59
Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol (2007) 8.47
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest (1999) 7.66
Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity (2005) 6.71
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis (2004) 6.54
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity (1995) 5.96
Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol (2000) 5.74
Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev (2003) 5.57
Therapeutic strategies for rheumatoid arthritis. N Engl J Med (2004) 5.51
Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol (2006) 4.83
IL-17: prototype member of an emerging cytokine family. J Leukoc Biol (2002) 4.39
CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol (1993) 3.74
IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol (1999) 3.52
Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem (2003) 3.41
IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol (1998) 3.37
A gender gap in autoimmunity. Science (1999) 3.33
The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol (2006) 2.98
IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol (2000) 2.93
Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol (2004) 2.73
Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun (2005) 2.66
Position paper: epidemiology of periodontal diseases. J Periodontol (2005) 2.46
T(H)-17 differentiation: of mice and men. Nat Immunol (2007) 2.40
A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol (2005) 2.36
Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol (1994) 2.28
The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol (2008) 2.21
Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine (2008) 2.19
A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res (2008) 2.05
CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun (1999) 2.05
Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum (2003) 2.04
Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol (2004) 2.03
Neutrophils, interleukin-17A and lung disease. Eur Respir J (2005) 1.86
Disease progression: identification of high-risk groups and individuals for periodontitis. J Clin Periodontol (2005) 1.70
Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect Immun (2000) 1.64
Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J Exp Med (2007) 1.47
Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine (1999) 1.45
Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol (2007) 1.43
The IL-17 cytokine family. Vitam Horm (2006) 1.39
Targeting the development and effector functions of TH17 cells. Semin Immunol (2008) 1.29
Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J Immunol (2005) 1.28
Infection-mediated early-onset periodontal disease in P/E-selectin-deficient mice. J Clin Periodontol (2001) 1.18
Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol (2004) 1.18
The role of acquired immunity and periodontal disease progression. Crit Rev Oral Biol Med (2003) 1.15
Impaired phagosomal maturation in neutrophils leads to periodontitis in lysosomal-associated membrane protein-2 knockout mice. J Immunol (2008) 1.15
The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol (2005) 1.13
Biology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Res Ther (2004) 1.11
Association of periodontal infections with atherosclerotic and pulmonary diseases. J Periodontal Res (1999) 1.06
Adhesion molecule deficiencies increase Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect Immun (2000) 1.01
Innate immunity to Toxoplasma gondii is influenced by gender and is associated with differences in interleukin-12 and gamma interferon production. Infect Immun (1997) 1.01
Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J Periodontol (2007) 0.97
Gender difference in cell-mediated immunity after thermal injury is mediated, in part, by elevated levels of interleukin-6. J Leukoc Biol (2000) 0.96
Neutrophil-mediated host response to Porphyromonas gingivalis. J Int Acad Periodontol (2002) 0.88
Asymmetry in periodontal bone loss of gnotobiotic Sprague-Dawley rats. Arch Oral Biol (1991) 0.83
Genetic control of the immune response in pathogenesis. J Periodontol (2005) 0.81
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol (2007) 10.71
Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med (2009) 5.55
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology (2010) 3.51
Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem (2003) 3.41
Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity (2009) 3.33
Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol (2004) 2.73
Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem (2006) 2.65
Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine (2008) 2.19
Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol (2004) 2.03
CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity (2011) 2.00
Th17 cells in immunity to Candida albicans. Cell Host Microbe (2012) 1.97
CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1. Mol Cell Biol (2004) 1.96
Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci U S A (2007) 1.85
Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. J Biol Chem (2004) 1.77
IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol (2008) 1.73
IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. J Immunol (2010) 1.69
NADPH oxidase limits innate immune responses in the lungs in mice. PLoS One (2010) 1.69
1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol (2011) 1.67
Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci (2008) 1.60
IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain. Sci Signal (2009) 1.57
Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol (2007) 1.43
Host responses to Candida albicans: Th17 cells and mucosal candidiasis. Microbes Infect (2010) 1.38
Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J Immunol (2009) 1.38
Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy. Arthritis Res Ther (2012) 1.33
The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes. Immunol Invest (2004) 1.31
Evidence for ligand-independent multimerization of the IL-17 receptor. J Immunol (2006) 1.29
IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev (2010) 1.23
B and T lymphocyte attenuator tempers early infection immunity. J Immunol (2009) 1.18
The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling. Sci Signal (2013) 1.16
IL-17RC: a partner in IL-17 signaling and beyond. Semin Immunopathol (2009) 1.14
Signaling through the murine T cell receptor induces IL-17 production in the absence of costimulation, IL-23 or dendritic cells. Mol Cells (2005) 1.13
Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. J Immunol (2014) 1.13
Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1 MAPK signaling affecting biofilm formation and oropharyngeal candidiasis. PLoS One (2012) 1.06
Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor. J Immunol (2007) 1.05
Histatin 5 uptake by Candida albicans utilizes polyamine transporters Dur3 and Dur31 proteins. J Biol Chem (2011) 1.02
CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptor-induced NF-kappaB activation. J Biol Chem (2007) 1.02
SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction. J Biol Chem (2010) 1.02
T cell-derived lymphotoxin regulates liver regeneration. Gastroenterology (2008) 1.01
Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17. J Immunol (2009) 1.01
A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. Eur J Immunol (2009) 0.98
IL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors. Cytokine (2013) 0.94
Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis. Infect Immun (2013) 0.91
TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. J Immunol (2011) 0.91
The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections. Infect Immun (2013) 0.90
Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway. J Biol Chem (2008) 0.89
Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge. Eur J Immunol (2014) 0.87
The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction. PLoS One (2013) 0.86
Anti-apoptotic signaling by the interleukin-2 receptor reveals a function for cytoplasmic tyrosine residues within the common gamma (gamma c) receptor subunit. J Biol Chem (2003) 0.84
Evolution in fast forward: a potential role for mutators in accelerating Staphylococcus aureus pathoadaptation. J Bacteriol (2012) 0.83
Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses. Arthritis Res Ther (2014) 0.79
IL-17 signaling and A20: a balancing act. Cell Cycle (2013) 0.79
Animal models for candidiasis. Curr Protoc Immunol (2014) 0.77
Is monocyte chemotactic protein 1 elevated in aseptic loosening of TKA? A pilot study. Clin Orthop Relat Res (2012) 0.77
A competitive infection model of hematogenously disseminated candidiasis in mice redefines the role of Candida albicans IRS4 in pathogenesis. Infect Immun (2013) 0.76
Correction: Role of Neutrophils in IL-17-Dependent Immunity to Mucosal Candidiasis. J Immunol (2015) 0.75